Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition

Zhang,Qingqing; Han,Meiling; Wang,Wenjuan; Song,Yunzhen; Chen,Gang; Wang,Zhong; Liang,Zhongqin

doi:10.3892/or.2015.3754

Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition

Authors:
- Qingqing Zhang
- Meiling Han
- Wenjuan Wang
- Yunzhen Song
- Gang Chen
- Zhong Wang
- Zhongqin Liang
View Affiliations

Affiliations: Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, P.R. China, Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China
Published online on: January 27, 2015 https://doi.org/10.3892/or.2015.3754
Pages: 1851-1859

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cathepsin L, a lysosomal acid cysteine protease, was found to be overexpressed in several types of human carcinomas. However, its functional roles in tumor progression and the underlying mechanisms remain largely unclear. In the present study, we investigated a novel functional aspect of cathepsin L in regulating transforming growth factor‑β (TGF‑β)‑induced epithelial‑mesenchymal transition (EMT) in A549 and MCF‑7 cells and examined its possible mechanisms. We found that TGF‑β‑induced cell morphologic changes of EMT were associated with the increased protein level of cathepsin L in A549 and MCF‑7 cells, suggesting that cathepsin L may be involved in the regulation of EMT. Furthermore, we showed that silencing of cathepsin L blocked TGF‑β‑induced cell migration, invasion and actin remodeling and inhibited TGF‑β‑mediated EMT. We also demonstrated that the mechanism of how cathepsin L knockdown regulates EMT may be explained by the suppression of EMT‑inducing molecules, such as Snail, which is associated with the phosphatidylinositol 3‑kinase (PI3K)‑AKT and Wnt signaling pathways. Moreover, we proved that cathepsin L knockdown in A549 cells significantly inhibited xenograft tumor growth and EMT in vivo. The results showed a new mechanism to determine cathepsin L involvement in the regulation of cancer invasion and migration. These results showed that cathepsin L knockdown is important in regulating EMT and suggest that cathepsin L may be utilized as a new target for enhancing the efficacy of chemotherapeutics against epithelial cancer.

View Figures

View References

1	Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
2	Fan F, Samuel S, Evans KW, Lu J, Xia L, Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA and Ellis LM: Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med. 1:5–16. 2012. View Article : Google Scholar
3	Shi J, Wang DM, Wang CM, Hu Y, Liu AH, Zhang YL, Sun B and Song JG: Insulin receptor substrate-1 suppresses transforming growth factor-β1-mediated epithelial-mesenchymal transition. Cancer Res. 69:7180–7187. 2009. View Article : Google Scholar : PubMed/NCBI
4	Voulgari A and Pintzas A: Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
5	Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED and Thompson EW: Epithelial - mesenchymal and mesenchymal - epithelial transitions in carcinoma progression. J Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
6	Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T and Miyazono K: Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res. 69:2783–2791. 2009. View Article : Google Scholar : PubMed/NCBI
7	Lim S, Becker A, Zimmer A, Lu J, Buettner R and Kirfel J: SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance. PLoS One. 8:e665582013. View Article : Google Scholar : PubMed/NCBI
8	Pardali K and Moustakas A: Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta. 1775:21–62. 2007.
9	Gupta M, Korol A and West-Mays JA: Nuclear translocation of myocardin-related transcription factor-A during transforming growth factor beta-induced epithelial to mesenchymal transition of lens epithelial cells. Mol Vis. 19:1017–1028. 2013.PubMed/NCBI
10	Naber HP, Drabsch Y, Snaar-Jagalska BE, et al: Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun. 435:58–63. 2013. View Article : Google Scholar : PubMed/NCBI
11	Levicar N, Nuttall RK and Lah TT: Proteases in brain tumor progression. Acta Neurochir. 145(Wien): 825–838. 2003. View Article : Google Scholar
12	Yong VW: Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci. 6:931–944. 2005. View Article : Google Scholar : PubMed/NCBI
13	Harada T, Arii S, Mise M, et al: Membrane-type matrix metalloproteinase-1(MT 1-MMP) gene is overexpressed in highly invasive hepatocellular carcinomas. J Hepatol. 28:231–239. 1998. View Article : Google Scholar : PubMed/NCBI
14	Wang JR, Li XH, Gao XJ, et al: Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 17:427–435. 2013.PubMed/NCBI
15	Brix K, Dunkhorst A, Mayer K and Jordan S: Cysteine cathepsins: cellular roadmap to different functions. Biochimie. 90:194–207. 2008. View Article : Google Scholar
16	Bylaite M, Moussali H, Marciukaitiene I, et al: Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases. Exp Dermatol. 15:110–118. 2006. View Article : Google Scholar : PubMed/NCBI
17	Stahl S, Reinders Y, Asan E, et al: Proteomic analysis of cathepsin B- and L-deficient mouse brain lysosomes. Biochimica Biophysica Acta. 1774:1237–1246. 2007. View Article : Google Scholar
18	Skrzydlewska E, Sulkowska M, Koda M and Sulkowski S: Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol. 11:1251–1266. 2005. View Article : Google Scholar : PubMed/NCBI
19	Navab R, Pedraza C, Fallavollita L, et al: Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. Oncogene. 27:4973–4985. 2008. View Article : Google Scholar : PubMed/NCBI
20	Pucer A, Castino R, Mirković B, et al: Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells. Biol Chem. 391:519–531. 2010. View Article : Google Scholar : PubMed/NCBI
21	Zajc I, Hreljac I and Lah T: Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics. Anticancer Res. 26:3357–3364. 2006.PubMed/NCBI
22	Strojnik T, Kos J, Zidanik B, et al: Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res. 5:559–567. 1999.PubMed/NCBI
23	Kirschke H, Eerola R, Hopsu-Havu VK, et al: Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur J Cancer. 36:787–795. 2000. View Article : Google Scholar : PubMed/NCBI
24	Gocheva V and Joyce JA: Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle. 6:60–64. 2007. View Article : Google Scholar : PubMed/NCBI
25	Jedeszko C and Sloane BF: Cysteine cathepsins in human cancer. Biol Chem. 385:1017–1027. 2004. View Article : Google Scholar : PubMed/NCBI
26	Mohamed MM and Sloane BF: Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer. 6:764–775. 2006. View Article : Google Scholar : PubMed/NCBI
27	Strojnik T, Kavalar R, Trinkaus M and Lah TT: Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Detect Prev. 29:448–455. 2005. View Article : Google Scholar : PubMed/NCBI
28	Chambers AF, Colella R, Denhardt DT and Wilson SM: Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol Carcinog. 5:238–245. 1992. View Article : Google Scholar : PubMed/NCBI
29	Frade R, Rodrigues-Lima F, Huang S, et al: Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res. 58:2733–2736. 1998.PubMed/NCBI
30	Yang Z and Cox JL: Cathepsin L increases invasion and migration of B16 melanoma. Cancer Cell Int. 7:82007. View Article : Google Scholar : PubMed/NCBI
31	Rousselet N, Mills L, Jean D, et al: Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res. 64:146–151. 2004. View Article : Google Scholar : PubMed/NCBI
32	Wang SM, Li L, Zhang W, et al: Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells. Zhonghua Fu Chan Ke Za Zhi. 45:598–602. 2010.(In Chinese). PubMed/NCBI
33	Lah TT, Durán Alonso MB and Van Noorden CJ: Antiprotease therapy in cancer: hot or not? Expert Opin Biol Ther. 6:257–279. 2006. View Article : Google Scholar : PubMed/NCBI
34	Goulet B, Sansregret L, Leduy L, et al: Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res. 5:899–907. 2007. View Article : Google Scholar : PubMed/NCBI
35	Krueger S, Kellner U, Buehling F, et al: Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype. Cancer Gene Ther. 8:522–528. 2001. View Article : Google Scholar : PubMed/NCBI
36	Matarrese P, Ascione B, Ciarlo L, et al: Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study. Mol Cancer. 9:2072010. View Article : Google Scholar : PubMed/NCBI
37	Shintani Y, Okimura A, Sato K, et al: Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg. 92:1794–1804. 2011. View Article : Google Scholar : PubMed/NCBI
38	Hao M, Zheng J, Hou K, et al: Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol. 84:204–214. 2012. View Article : Google Scholar : PubMed/NCBI
39	Bi WR, Jin CX, Xu GT and Yang CQ: Bone morphogenetic protein-7 regulates Snail signaling in carbon tetrachloride-induced fibrosis in the rat liver. Exp Ther Med. 4:1022–1026. 2012.PubMed/NCBI
40	Nieto MA: The Snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 3:155–166. 2002. View Article : Google Scholar : PubMed/NCBI
41	Shin SY, Rath O, Zebisch A, et al: Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition. Cancer Res. 70:6715–6724. 2010. View Article : Google Scholar : PubMed/NCBI
42	Eger A, Stockinger A, Park J, et al: beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene. 23:2672–2680. 2004. View Article : Google Scholar : PubMed/NCBI
43	Xiao D and He J: Epithelial mesenchymal transition and lung cancer. J Thorac Dis. 2:154–159. 2010.PubMed/NCBI
44	Chunhacha P, Sriuranpong V and Chanvorachote P: Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells. Oncol Lett. 5:1043–1047. 2013.PubMed/NCBI
45	Davies M, Robinson M, Smith E, et al: Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem. 95:918–931. 2005. View Article : Google Scholar : PubMed/NCBI
46	Amuthan G, Biswas G, Ananadatheerthavarada HK, et al: Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene. 21:7839–7849. 2002. View Article : Google Scholar : PubMed/NCBI
47	Krueger S, Kellner U, Buehling F and Roessner A: Cathepsin L antisense oligonucleotides in a humall osteosarcoma cell line: efects on the invasive phenotype. Cancer Gene Ther. 8:522–528. 2001. View Article : Google Scholar : PubMed/NCBI
48	Gocheva V, Zeng W, Ke D, et al: Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20:543–556. 2006. View Article : Google Scholar : PubMed/NCBI
49	Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
50	Zhang Q, Bai X, Chen W, et al: Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis. 34:962–973. 2013. View Article : Google Scholar : PubMed/NCBI
51	Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
52	Hanahan D: Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 315:115–122. 1985. View Article : Google Scholar : PubMed/NCBI
53	Lee SY, Jeon HM, Ju MK, et al: Wnt/Snail signaling regulates cytochrome c oxidase and glucose metabolism. Cancer Res. 72:3607–3617. 2012. View Article : Google Scholar : PubMed/NCBI
54	Kumawat K, Menzen MH, Slegtenhorst RM, Halayko AJ, Schmidt M and Gosens R: TGF-β-activated kinase 1 (TAK1) signaling regulates TGF-β-induced WNT-5A expression in airway smooth muscle cells via Sp1 and β-catenin. PLoS One. 9:e948012014. View Article : Google Scholar